Pharmacopeia

CWP-0178

NEURAMINIDASE INHIBITORS

Anti-infectives · Level 3

Core pharmacology

Class Group

Antiviral

Introduction

Oseltamivir and Zanamivir

Mechanism of action

inhibit neurominidase resulting in impaired viral release from infected cells. Neurominidase cleaves the sialic acid on the cell membrane allowing viral budding.

Adverse Effects Toxicity

1. Psychiatric symptoms
2. N/V/D
3. Bronchospasm